pegcetacoplan
sobi,Apellis Pharmaceuticals
['obinu']
today, we announced new analyses from our phase 3 clinical program in paroxysmal nocturnal hemoglobinuria (#pnh) at the congress. read more. #leadersincomplement 
Global biopharma company leveraging courageous science, creativity, and compassion to deliver life-changing therapies. #LeadersInComplement #CourageousScience